Global Oral Clinical Nutrition Supplement Market Size study, by Product Type (Standard Formula, Specialised Formula) by Indication (General Well-being, Renal Disorders, Hepatic Disorders, Oncology Nutrition, Diabetes, Dysphagia, IBD & GI Tract Disorders, Neurological Disorders, Respiratory Orders, Others) by Form (Liquid, Semi-solid, Powder) by Flavor (Regular, Flavored) by Channel (Prescription-based, Over-the-Counter) by End User (foods & beverages, Pharmaceutical, Textiles, Petrochemicals, Adhesives, others) and Regional Forecasts 2022-2028
Global Oral Clinical Nutrition Supplement Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Nutrition Supplement refers to dietary supplements which contains essential vitamins, minerals, amino acids, and enzymes etc. oral nutrition supplements used to lower risk of health problems such as metabolism disorders, osteoporosis, or arthritis. Growing demand for herbal dietaries supplements and growing geriatric population are key drivers for the growth of Oral Clinical Nutrition Supplement market. For instance, according to the Nutrition Business Journal (NBJ)- In 2020 sales of Herbal dietary supplement in the United States estimated at USD 11.261 billion, an increase of 17.3% from the sales in the year 2019 (approx. USD 9.60 billion). Also, in July 2021 Lycored in partnership with Herbalife Nutrition launched a new oral herbal supplement skin product, LycoGlow. Also, with the rising health concerns among the population and growing disposable income, the adoption & demand for Oral Clinical Nutrition Supplement is likely to increase the market growth during the forecast period. However, stringent government regulations and low affordability due to high cost of nutrition supplement may impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the Global Oral Clinical Nutrition Supplement Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share owing to increasing demand for nutrition supplement in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate over the forecast period 2022-2028. Factors such as increasing incidences of chronic diseases and rising disposable income would create lucrative growth prospects for the Oral Clinical Nutrition Supplement market across Asia-Pacific region.
Major market player included in this report are:
NUTRICIÓN MÉDICA SL
Meiji Holdings Co., Ltd.
Medtrition Inc.
Baxter International Inc.
B. Braun Melsungen AG.
Fresenius Kabi AG
Mead Johnson & Company, LLC
Otsuka Holdings Co., Ltd.
Abbott Laboratories
Danone Nutricia
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Standard Formula
Specialised Formula
By Indication:
General Well-being
Renal Disorders
Hepatic Disorders
Oncology Nutrition
Diabetes
Dysphagia
IBD & GI Tract Disorders
Neurological Disorders
Respiratory Orders
Others
By Form:
Liquid
Semi Solid
Powder
By Flavor:
Regular
Flavored
By Channel:
Prescription-based
Over the Counter
By End User:
Adult
Geriatric
Paediatric
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Oral Clinical Nutrition Supplement Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Companies Mentioned
NUTRICIÓN MÉDICA SL
Meiji Holdings Co., Ltd.
Medtrition Inc.
Baxter International Inc.
B. Braun Melsungen AG.
Fresenius Kabi AG
Mead Johnson & Company, LLC
Otsuka Holdings Co., Ltd.
Abbott Laboratories
Danone Nutricia
Please note: The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook